Is the ‘vibecession’ really coming to an end? What’s the latest on Pharmaceutical acquisitions? And why are Chinese gaming firms unveiling share buybacks even after the latest regulatory move unnerved investors? Michelle Martin discusses with Ryan Huang.

Is the ‘vibecession’ really coming to an end? What’s the latest on Pharmaceutical acquisitions? And why are Chinese gaming firms unveiling share buybacks even after the latest regulatory move unnerved investors? Michelle Martin discusses with Ryan Huang.

Your Money With Michelle Martin (9am - 12pm) It’s all about Your Money with Michelle Martin from 9am to 12pm. How to save, invest and make the best financial decisions for yourself. Listen to inspiring thinkers with “Influence” and hear from great authors in “Read”.

Your Money With Michelle Martin (9am - 12pm) It&rsquo;s all about Your Money with Michelle Martin from 9am to 12pm. How to save, invest and make the best financial decisions for yourself. Listen to inspiring thinkers with &ldquo;Influence&rdquo; and hear from great authors in &ldquo;Read&rdquo;.

Your Money with Michelle Martin

It’s all about Your Money with Michelle Martin from 9am to 12pm. How to save, invest and make the best financial decisions for yourself. Listen to inspiring thinkers with “Influence” and hear from great authors in “Read”.

It&rsquo;s all about Your Money with Michelle Martin from 9am to 12pm. How to save, invest and make the best financial decisions for yourself. Listen to inspiring thinkers with &ldquo;Influence&rdquo; and hear from great authors in &ldquo;Read&rdquo;.

Your Money with Michelle Martin (9am - 12pm)

Market View: Bristol Myers $4.1 billion acquisition, Microstrategy, Intel, Adani Green, Apple, Vibecession ending, Chinese gaming firms share buybacks, Goldman’s 2023 lesson on China, Astrazeneca buys Cancer Drug Developer for $1.2 billion

Advertisement